Búsquedas manteniendo la privacidad con

Portada / Gobierno Mundial / Genocidio / S.I.D.A. /
Lista de enfermedades y situaciones que generan reacciones cruzadas con los test



Factores que causan resultados positivos en las pruebas que pretenden detectar anticuerpos al supuesto VIH

  • Administración de preparados de inmunoglobulina humana recogidos antes de 1985 (10).
  • Anticuerpos al HLA (a antigenos de los leucocitos Tipo I y II) (7, 10, 13, 43, 46, 48, 49, 53, 63).
  • Anticuerpos anti-células parietales (48).
  • Anticuerpos anticolágenos (encontrados en hombres homosexuales, hemofílicos, africanos de ambos sexos y personas con lepra) (31).
  • Anticuerpos-antihidratos de carbono (13, 19, 52).
  • Anticuerpos antilinfocitos (31, 56).
  • Anticuerpos antimicrosomiales (34).
  • Anticuerpos antimitocondriales (13, 48).
  • Anticuerpos anti-músculos lisos (48).
  • Anticuerpos antinucleares (13, 48, 53).
  • Anticuerpos con una alta afinidad con el polistireno (utilizado en los equipos de pruebas) (3, 40, 62).
  • Anticuerpos del antígeno de leucocitos de las células T (13, 48).
  • Anticuerpos que se dan de forma natural (5, 19).
  • Artritis reumatoide (36).
  • Cirrosis biliar primaria (13, 43, 48, 53).
  • Colangitis esclerosante primaria (48, 53).
  • Embarazo en mujeres multíparas (13, 36, 43, 53, 58).
  • Enfermedades autoinmunes (10, 29, 40, 43, 44, 49).
  • Especímenes tratados con calor (24, 48, 49, 51, 57).
  • Exposición a vacunas víricas o infección vírica recientes (11).
  • Falsos positivos a otras pruebas, incluyendo el test RPR (rapid plasma reagent) para la sífilis (10, 17, 33, 48, 49).
  • Fiebre Q con hepatitis asociada (61).
  • Globulinas producidas durante gammopatías policlonales (que se observan en grupos de riesgos de SIDA) (10, 13, 48).
  • Gripe (36).
  • Hemofilia (10, 49).
  • Hepatitis (54).
  • Hepatitis alcohólica / enfermedad hepática alcohólica (10, 13, 32, 40, 43, 48, 49, 53).
  • Herpes simple I (27).
  • Herpes simple II (11).
  • Hiperbilirrubinemia (10, 13).
  • Hipergammaglobulemia (niveles altos de anticuerpos) (33, 40).
  • IgM anti-Hbc (48).
  • IgM (anticuerpos) anti-hepatitis A (48).
  • Individuos sanos como resultado de reacciones cruzadas mal entendidas (10).
  • Infección de las vías respiratorias superiores (resfriado o gripe) (11).
  • Infecciones víricas agudas, infecciones víricas del ADN (13, 40, 43, 48, 53, 59).
  • Inmunización pasiva: recepción de gammaglobulina o inmunoglobulina (como profilaxis contra infección que contiene anticuerpos) (4, 13, 18, 22, 26, 42, 43, 60).
  • Insuficiencia renal (13, 23, 48).
  • Insuficiencia renal / Hemodiálisis (10, 16, 41, 49, 56).
  • Leishmaniasis visceral (45).
  • Lepra (2, 25).
  • Lupus eritematoso sistémico (15, 23).
  • Lupus eritematoso sistémico, escleroderma, enfermedad del tejido conjuntivo, dermatomiositis.
  • Malaria (6, 12).
  • Micobacterium avium (25).
  • Mieloma múltiple (10, 43, 53).
  • Neoplasmas malignos (cánceres) (40).
  • Niveles altos de complejos inmunes circulantes (6, 33).
  • Otros retrovirus (8, 13, 14, 48, 55).
  • Proteínas en el papel de filtro (13).
  • Ribonucleoproteínas humanas normales (13, 48).
  • Sangre «pegajosa» (en africanos) (34, 38, 40).
  • Seropositivos al factor reumatoide, anticuerpos antinucleares (ambos encontrados en la artritis reumatoide y otros autoanticuerpos) (14, 53, 62).
  • Sexo anal receptivo (39, 64).
  • Síndrome de Stevens-Johnson (9, 13, 48).
  • Suero hemolizado (sangre en la que la hemoglobina se separa de las células rojas) (49).
  • Suero lipémico (sangre con niveles altos de grasas o lípidos) (49).
  • Terapia de alfa interferón en pacientes de hemodiálisis (54).
  • Transfusiones sanguíneas, transfusiones sanguíneas múltiples (13, 36, 43, 49, 53, 63).
  • Transplante de órganos (1, 36).
  • Transplante de riñón (9, 13, 35, 48, 56).
  • Trastornos hematológicos malignos / linfomas (9, 13, 43, 48, 53).
  • Tuberculosis (25).
  • Vacunación de la gripe (3, 11, 13, 20, 30, 43).
  • Vacunación de la hepatitis B (21, 28, 40, 43).
  • Vacunación del tétanos (40).
  • Virus Epstein-Barr (37).

 

Referencias:

1. Agbalika F., Fercahl F., Garnier J-P, et al. 1992. False-positive antigens related to emergence of a 25-30 protein detected in organ recipients.
2. Andrade V., Avelleira JC., Marques A., et al, 1991. Leprosy as a cause of false-positive results in serological assays for the detection of antibodies to HIV-1. Intl. J. Leprosy. 59:125.
3. Arnold Nl., Slade R.A., Jones M.M., et al, 1994. Donor follow up of influenza vaccine-related multiple viral enzume inmunoassay reactivity. Vox Sanguinis. 67:191.
4. Ascher D., Roberts C. 1993. Determination of the etiology of seroreversals in HIV testing by antibody fingerprinting AIDS. 6:241.
5. Barbacid M., Bolgnesi D., Aaronson S. 1980. Humans have antibodies capable of recognizing oncoviral glucoproteins: Demostration that these antibodies are formed in response to cellular modification of glucoproteins rather than as consequence of exposure to virus. Proc. Nathl. Acad. Sci. 77:1617-1621.
6. Biggar R., Melbye M., Sarin P., et al., 1985. ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancet. ii:520-543.
7. Blanton M., Balakrishnan K., Dumaswala U., et al, 1987. HLA antibodys in blood donors with reactive sreening tests for antibodys to the immunodeficiency virus. Transfusión. 27 (1):118.
8. Blomberg J., Vincie E., Jonsson C., et al. 1990. Identification of long susthetic peptides AIDS Res. Hum. Retro. 6:1363.
9. Burkhardt U., Metens T., Eggers H. 1987. Comparison of ELA and DuPont HTIV-III ELISA. J. Med. Vir. 23:217.
10. Bylund D., Ziegner U., Hooper D. 1992. Review of testing for human immunodeficiency virus. Clin. Lab. Med. 12:305-333.
11. Challakere K., Rapaport M. 1993. False-positive human inmunodeficiency virus type I ELISA results in low-risk subjects West. J. Med. 159(2):214-215.
12. Charmot G., Simon F. 1990. HIV infection and malaria. Revue du practicien, 40:2141.
13. Cordes R., Ryan M. 1995. Pittalls in HIV testing. Postgraduate Medicine. 98:177.
14. Dock N., Lamberson H., O'Brien T., et al., 1988. Evaluation of atypical human immunodeficiency virus immunoblot reactivity in blood donors. Transfusion 28:142.
15. Esteva M., Blasini A., Ogly D., et al, 1992. False positive results for antibody to HIV in two men with systemic lupus erythematosus. Ann. Rheum. Dis., 51:1071-1073.
16 Fassbinder W., Kuhni P., Neumaver H., et al, 1986. Prevalence of antibodies against LAV/HTLV-III (MIV) in patients with termical renal insufficiency treated with hemodialysis and following renal transplantation. Deutsche Medizinische Wochenschrift 111:1087.
17. Fleming D., Cochi S., Steece R., et al, 1987. Acquired immunodeficiency syndrome in low-incidence areas. JAMA 258(6):785.
18. Gill MJ., Rachlis A., Anand C. 1991. Five cases of erroncously diagnosed HIV infection. Can. Med. Asso. J. 145(12):1593.
19. Healey D., Bolton iW. 1993. Apparent HIV-I glycoprotein reactivity on Western blot in uninfected blood donors. AIDS. 7:655-658.
20. Hisa J., 1993. False-Positive ELISA for human immunodeficiency virus after influenza vaccination HD. 167:989.
21. Isaacman S. 1989. Positive HIV antibody test results after treatment with hepatitis B immune globulin. JAMA, 262:209.
22. Jackson G., Rubens M., Knigge M., et al, 1988. Passive immunoneutralisation of human immunodeficiency virus in patients with advanced AIDS. Lancet. Sept. 17:647.
23. Jindal R., Solomon M., Burrows L. 1993. False positive tests for HIV in a woman with lupus and renal failune. NEJM. 328:1281-1282.
24. Jungkind D., DiRenzo S., Young S. 1986. Effect of using heat inactivated serum with the Abbott human T-cell lymphotropic virus type III (HIV) antibody test. J. Clin. Micro. 23:381.
25. Kashala O., Marlink R., Ilunga M. et al. 1994. Infection with human immunodeficiency virus type I (HIV-I) and human T-cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-1 cross-reactivity and antibodies to lipoarabionomanna J. Infect. Dis. 169:296-304.
26. Lai-Godman M., McBride J., Howanitz P., et al, 1987. Presence of HTLV-III (HIV) antibodies in immuneserum globulin preparations. Am. J. Clin. Path. 87:635.
27. Langedjk J., Vos W., Doornum G., et al. 1992. Identification of cross-reactive epitopes recognized by HIV-1 fase-positive será. AIDS. 6:1546-1548.
28. Lee D., Eby W., Molinaro G. 1992. HIV false positivity after hepatitis B vaccination. Lancet 339:1060.
29. Leo-Amador G., Ramírez-Rodríguez J., Galván-Villegas E., et al, 1990. Antibodies against human immunodeficiency virus in generalized lupus erythematosus. Salud Pública de México. 32:15.
30. Mackenzie W., Davis J., Peterson D., et al. 1992. Multiple false-positive serologie tests for HIV, HTLV-1 and hepatitis C following influenza vaccination. 1991. JAMA. 268:1015-1017.
31. Mathe G. 1992. Is the AIDS virus responsible for the disease?. Biomed & Pharmacother. 46:1-2.
32. Mendenhall C., Roselle G., Grossman C., et al. 1986. False-positive tests for HTLV-III (HIV) antibodies in alcoholic patients with hepatitis. NEJM. 314:921.
33. Moore J., Cone E., Alexander S. 1986. HTLV-III (HIV) seropositivity in 1971-1972 parenteral drug abusers -a case of false-positives or evidence of viral exposure?. NEJM. 314:1387-1388.
34. Mortimer I., Mortimer J., Parry J. 1985. Which anti-HTLV-III/LAV (HIV) assays for screening and comfirmatory testing?. Lancet. Oct 10. p. 837.
35. Ncale T., Dagger J., Fong R., et al. 1985. False-positive anti-HTLV-III (HIV) serology. New Zealand Med. J. October 23.
36. Ng V. 1991. Serological diagnosis with recombinant peptides/proteins. Clin. Chem. 37:1667-1668.
37. Ozanne G., Fauvel M. 1988. Perfomance and reliability of five commercial enzyme.linked immunosorbent assay kits in screening for anti-human immunodeficiency virus antibody in high-risk subjects. J. Clin. Micro, 26:1496.
38. Papadopulos-Eleopulos E. 1988. Reappraisal of AIDS -Is the oxidation induced by the risk factors the primary cause?. Med. Hypo. 25:151.
39. Papadopulos-Eleopulos E., Turner V. and Papadimitriou J. 1993. Is a positive Western blot proof of HIV infection?. Bio/technology. June 11:696/707.
40. Pearlman ES., Ballas SK. 1994. False-positive human immunodeficiency virus screening test related to rabies vaccination. Arch. Pathol. Lab. Med. 118-805.
41. Peternan T., Lang G., Mikos N., et Hemodialysis/renal failure. 1986. JAMA. 255:2324.
42. Piszkewiez D. 1987. HTLV-III (HIV) antibodies after immune globulin. JAMA. 257:316.
43. Profitt MR., Yen-Lieberman B. 1993. Laboratory diagnosis of human immunodeficiency virus infection. Inf. Dis. Clin. North. Am. 7:203.
44. Ranki A., Kurti P., Reipponen S., et al. 1992. Antibodies to retroviral proteins in autoimmune connective tissue disease. Arthritis and Rheumatism. 35:1483.
45. Ribero T., Bries C., Moreira E., et al. 1993. Serologie validation of HIV infection in a tropical area. JAIDS. 6:319.
46. Savers M., Beatty P., Hansen J. 1986. HLA antibodies as a cause of false-positive reactions in screening enzyme immunoassays for antibodies to human T-lymphotropic virus type III (HIV). Transfusion. 26(1):114.
47. Sayre KR., Dodd RY., Tegtmeier G., et al, 1996. False-positive human immunodeficiency virus type 1 Western blot tests in non infected blood donodrs. Transfusion. 36:45.
48. Schleupner CJ. Detection of HIV-1 infection. In: (Mandell GI., Douglas RG., Bennet JE., eds.). Principles and Practice of Infectious Diseases, 3rd ed. New York: Churchill Livingstone. 1990:1092.
49. Schochetman G., George J. 1992. Serologic tests for the detection of human immunodeficiency virus infection. In AIDS Testing Methodology and Management Issues, Springer-Verlag. New York.
50. Simonsen L., Buffington J., Shapiro C., et al. 1995. Multiple false reactions in viral antibody screening assays after influenza vaccination. Am. J. Epidem. 141:1089.
51. Smith D., Dewhurst S., Shepherd S., et al. 1987. False-positive enzyme-linked immunosorbent assay reactions for antibody to human immunodeficiency virus in a population of midwestern patients with congenital bleeding disorders. Transfusion. 127:112.
52. Snyder H., Fleissner E. 1980. Specifity of human antibodies to oncovirus glucoproteins; Recognition of antigen by natural antibodies directed against carbohydrate structures. Proc. Natl. Acad. Sci. 77:1622-1626.
53. Steckelberg JM., Cockerill F. 1988. Serologie testing for human immunodeficiency virus antibodies. Mayo Clin. Proc. 63:373.
54. Sungar C., Akpolat T., Ozkuyumen C., et al. Alpha interferon therapy in hemodialysis patients. Nephron. 67:251.
55. Tribe D., Reed D., Lindell P., et al. 1988. Antibodies reactive with human immunodeficiency virus gag-coated antigens (gag reactive only) are a major cause of enzyme-linked immunosorbent assay reactivity in a bood donor population. J. Clin. Micro. April:641.
56. Ujhelyi E., Fust G., Illei G., et al. 1989. Different types of false positive anti-HIV reactions in patients on hemodialysis. Immun. Let. 22:35-40.
57. Van Beers D., Duys M. Maes M., et al. Heat inactivation of serum may interfere with tests for antibodies to LAV/HTLV-III (HIV). J. Vir. Meth. 12:329.
58. Voevodin A. 1992. HIV screening in Russia. Lancet. 339:1548.
59. Weber B., Moshtaghi-Borogeni M., Brunner M., et al. 1995. Evaluation of the reliability of six current anti-HIV-1/HIV-2 enzyme immunoassays. J. Vir. Meth. 55:97.
60. Wood C., Williams A., McNamara J., et al. 1986. Antibody against the human immunodeficiency virus in commercial intravenous gammaglobulin preparations. Ann. Int. Med. 105:536.
61. Yale S., Degroen P., Tooson J., et al. 1994. Unusual aspects of acute Q fever-associated hepatitis. Mayo Clin. Proc. 69:769.
62. Yoshida T., Matsui T., Kobayashi M., et al. 1987. Evaluation of passive particle agglutination test for antibody to human immunodeficiency virus. J. Clin. Micro. Aug:1433.
63. Yu S., Fong C., Landry M., et al. 1989. A false positive HIV antibody reaction due to transfusion-induced HLA-DR4 sensitization. NEJM. 320:1495.
64. National Institute of Justice. AIDS Bulletin. Oct. 1988.

Artículo publicado en el número 47 de la revista «Medicina Holística».
Edita: Asociación de Medicinas Complementarias

 

 

 


Portada / Gobierno Mundial / Genocidio / S.I.D.A. /
Lista de enfermedades y situaciones que generan reacciones cruzadas con los test

 

 

Ixquick
Buscar en free-news.org Buscar en internet